Special Emphasis on Bioanalytical Method Development and Validation of an Anti-Hypertensive Drug Azelnidipine by LC-ESI-MS/MS in Healthy Human Volunteer’s Blood Plasma

Dibya Das; Dhiman Halder; Himangshu Sekhar Maji; Pintu Kumar De; Tapan Kumar Pal

doi:10.52711/0974-360X.2021.00618

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Special Emphasis on Bioanalytical Method Development and Validation of an Anti-Hypertensive Drug Azelnidipine by LC-ESI-MS/MS in Healthy Human Volunteer’s Blood Plasma

Author(s): Dibya Das, Dhiman Halder, Himangshu Sekhar Maji, Pintu Kumar De, Tapan Kumar Pal

Email(s): dibyadas1990gmail.com

DOI: 10.52711/0974-360X.2021.00618

Address: Dibya Das1*, Dhiman Halder2, Himangshu Sekhar Maji1, Pintu Kumar De1, Tapan Kumar Pal2
1Department of Pharmaceutical Technology, JIS University, Kolkata.
2Department of Pharmaceutical Technology, Bioequivalence Study Centre, Jadavpur University, Kolkata.
*Corresponding Author

Published In: Volume - 14, Issue - 7, Year - 2021

Keywords:

Cite this article:
Dibya Das, Dhiman Halder, Himangshu Sekhar Maji, Pintu Kumar De, Tapan Kumar Pal. Special Emphasis on Bioanalytical Method Development and Validation of an Anti-Hypertensive Drug Azelnidipine by LC-ESI-MS/MS in Healthy Human Volunteer’s Blood Plasma. Research Journal of Pharmacy and Technology. 2021; 14(7):3571-7. doi: 10.52711/0974-360X.2021.00618

View PDF